BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37678613)

  • 41. Complete dissection of right paratracheal lymph nodes (stations 2R and 4R) is critical to improve the prognosis of lung cancer patients: A retrospective cohort study.
    Zhao K; Mei J; Hu B; Guo C; Wei S; Yang X; Yang Z; Zhang J; Ku Y; Zheng Y; Wu D; Li S; Mao Y; Ding Y; Liu L
    Thorac Cancer; 2023 Nov; 14(33):3309-3316. PubMed ID: 37789589
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Number of mediastinal lymph nodes in non-small cell lung cancer: a Gaussian curve, not a prognostic factor.
    Riquet M; Legras A; Mordant P; Rivera C; Arame A; Gibault L; Foucault C; Dujon A; Le Pimpec Barthes F
    Ann Thorac Surg; 2014 Jul; 98(1):224-31. PubMed ID: 24820386
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lymph node dissection and survival in patients with early stage nonsmall cell lung cancer: A 10-year cohort study.
    Shen-Tu Y; Mao F; Pan Y; Wang W; Zhang L; Zhang H; Cheng B; Guo H; Wang Z
    Medicine (Baltimore); 2017 Oct; 96(43):e8356. PubMed ID: 29069017
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of mediastinal lymph nodes sampling in patients with clinical stage I non-small cell lung cancer.
    Takizawa H; Kondo K; Matsuoka H; Uyama K; Toba H; Kenzaki K; Sakiyama S; Tangoku A; Miura K; Yoshizawa K; Morita J
    J Med Invest; 2008 Feb; 55(1-2):37-43. PubMed ID: 18319543
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of selective lymph node dissection based on patterns of lobe-specific lymph node metastases on patient outcome in patients with resectable non-small cell lung cancer: a large-scale retrospective cohort study applying a propensity score.
    Ishiguro F; Matsuo K; Fukui T; Mori S; Hatooka S; Mitsudomi T
    J Thorac Cardiovasc Surg; 2010 Apr; 139(4):1001-6. PubMed ID: 19733863
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lymph node evaluation achieved by open lobectomy compared with thoracoscopic lobectomy for N0 lung cancer.
    Merritt RE; Hoang CD; Shrager JB
    Ann Thorac Surg; 2013 Oct; 96(4):1171-1177. PubMed ID: 23915591
    [TBL] [Abstract][Full Text] [Related]  

  • 47. European trends in preoperative and intraoperative nodal staging: ESTS guidelines.
    De Leyn P; Lardinois D; Van Schil P; Rami-Porta R; Passlick B; Zielinski M; Waller D; Lerut T; Weder W;
    J Thorac Oncol; 2007 Apr; 2(4):357-61. PubMed ID: 17409811
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Significance of the number of positive lymph nodes in resected non-small cell lung cancer.
    Fukui T; Mori S; Yokoi K; Mitsudomi T
    J Thorac Oncol; 2006 Feb; 1(2):120-5. PubMed ID: 17409840
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Maximizing lymph node dissection from fresh lung cancer specimens.
    Raymond C; Vieira A; Joubert P; Ugalde PA
    Eur J Cardiothorac Surg; 2022 Dec; 63(1):. PubMed ID: 36469356
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sentinel node sampling limits lymphadenectomy in stage I non-small cell lung cancer.
    Muraoka M; Akamine S; Oka T; Tagawa T; Nakamura A; Tsuchiya T; Hayashi T; Nagayasu T
    Eur J Cardiothorac Surg; 2007 Aug; 32(2):356-61. PubMed ID: 17513118
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Does Lymph Node Count Influence Survival in Surgically Resected Non-Small Cell Lung Cancer?
    David EA; Cooke DT; Chen Y; Nijar K; Canter RJ; Cress RD
    Ann Thorac Surg; 2017 Jan; 103(1):226-235. PubMed ID: 27469339
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical Predictors of Nodal Metastases in Peripherally Clinical T1a N0 Non-Small Cell Lung Cancer.
    Ghaly G; Rahouma M; Kamel MK; Nasar A; Harrison S; Nguyen AB; Port J; Stiles BM; Altorki NK; Lee PC
    Ann Thorac Surg; 2017 Oct; 104(4):1153-1158. PubMed ID: 28551047
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A multicenter propensity score-matched analysis of lymphadenectomy in N1-positve lung cancer.
    Handa Y; Tsutani Y; Mimae T; Miyata Y; Ito H; Shimada Y; Nakayama H; Ikeda N; Okada M
    Jpn J Clin Oncol; 2023 Dec; 53(12):1183-1190. PubMed ID: 37622593
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Do tumours located in the left lower lobe have worse outcomes in lymph node-positive non-small cell lung cancer than tumours in other lobes?
    Kudo Y; Saji H; Shimada Y; Nomura M; Usuda J; Kajiwara N; Ohira T; Ikeda N
    Eur J Cardiothorac Surg; 2012 Sep; 42(3):414-9. PubMed ID: 22398463
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Adequacy of Intraoperative Nodal Staging during Surgical Resection of NSCLC: Influencing Factors and Its Relationship to Survival.
    Edwards T; Balata H; Elshafi M; Foden P; Bishop P; Fontaine E; Jones M; Krysiak P; Rammohan K; Shah R; Crosbie P; Booton R; Evison M
    J Thorac Oncol; 2017 Dec; 12(12):1845-1850. PubMed ID: 28782727
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Lymph node dissection in patient operated for non small cell lung cancer in early stage].
    Kolesnik AP
    Klin Khir; 2013 Sep; (9):56-9. PubMed ID: 24501931
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The role of lymphadenectomy in lung cancer surgery.
    D'Andrilli A; Venuta F; Rendina EA
    Thorac Surg Clin; 2012 May; 22(2):227-37. PubMed ID: 22520290
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Adequate lung cancer surgery lymphadenectomy within a statewide quality collaborative: Quality improvement in action.
    Kalata S; Lam GT; Alnajjar RM; Clark MJ; He C; Welsh RJ; Chang AC; Lagisetty KH
    J Thorac Cardiovasc Surg; 2023 Jul; 166(1):241-250.e3. PubMed ID: 36456358
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Morbidity, survival, and site of recurrence after mediastinal lymph-node dissection versus systematic sampling after complete resection for non-small cell lung cancer.
    Lardinois D; Suter H; Hakki H; Rousson V; Betticher D; Ris HB
    Ann Thorac Surg; 2005 Jul; 80(1):268-74; discussion 274-5. PubMed ID: 15975380
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Completeness of lymph node dissection in patients undergoing minimally invasive- or open surgery for non-small cell lung cancer: A nationwide study.
    van der Woude L; Wouters MWJM; Hartemink KJ; Heineman DJ; Verhagen AFTM
    Eur J Surg Oncol; 2021 Jul; 47(7):1784-1790. PubMed ID: 33223414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.